Prestige Biologics Co., Ltd. · 임원ㆍ주요주주특정증권등소유상황보고서
Report on Specified Securities Owned by Officers and Major Shareholders
6.1
프레스티지바이오로직스(주)
20261104
Report on Specified Securities Owned by Officers and Major Shareholders
| To: Securities and Futures Commission | ||
| To: Korea Exchange | ||
| Reporting obligation date: | 2026-11-04 | |
| Report reference date: | 2026-11-09 | |
| ※ The reporting person confirms that ownership of specified securities as of the reference date is accurately stated per applicable laws and filing instructions, with no material misstatement or omission. |
| Reporting person: | 임영수 |
| Company Name | 프레스티지바이오로직스(주) | ||
| Entity type | KOSDAQ-Listed Company | Company code | 334970 |
| Total Shares Issued | 77,752,637 | ||
| Report Type | Change | Reporting person type | Individual (Domestic) | |
| Name (Entity Name) | Korean | 임영수 | Chinese characters (English) | 林 永 洙(Lim Young Soo) |
| Date of Birth or Business Registration No., etc. | 630615 | |||
| Address (Head Office) [Town/District Level Only] | 서울특별시 서초구 서초대로 | |||
| Relationship to Issuer | Officer (Registered or Not) | Registered Officer | Position | CEO |
| Appointment Date | 2026-10-30 | Resignation Date | - | |
| Major Shareholder | - | |||
| Business contact and person in charge | Affiliated company | 프레스티지바이오로직스(주) | Department | Finance team |
| Position | Deputy General Manager | Phone Number | 043-23** | |
| Name | 김영송 | Fax number | 043-23** | |
| Email address | **@prestigebio.com | |||
| Report reference date | Specified Securities | Share Certificates | |||
| Number of Specified Securities (shares) | Ratio (%) | Number of Shares (shares) | Ratio (%) | ||
| Previous Report | 2023-12-22 | 18,449 | 0.03 | 18,449 | 0.03 |
| This Report | 2026-11-09 | 155,949 | 0.20 | 155,949 | 0.20 |
| Change | 137,500 | 0.17 | 137,500 | 0.17 | |
| Details of Specified Securities | |||||||||
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Participating Bonds | Exchangeable bonds | Depositary receipts | Other | Total | |
| Number of shares | Ratio (%) | ||||||||
| 155,949 | - | - | - | - | - | - | - | 155,949 | 0.20 |
| A | B | C | D | E | F | G | H | ||
| I | |||||||||
| Total Shares Issued (J) | Number of Specified Securities Other Than Shares (B+C+D+E+F+G+H=I) | Ownership ratio (%) | |
| Ownership Ratio of Specified Securities [A+I / J+I-(F+G+H)※] × 100 | Shareholding Ratio (A / J) × 100 | ||
| 77,752,637 | - | 0.20 | 0.20 |
※ Ownership ratio excludes from the denominator only exchangeable bonds exchangeable into shares and depositary receipts, derivative-linked securities, etc. with shares as underlying
| Reason for Report | Change Date* | Type of Specified Securities | Shares Owned (shares) | Acquisition/Disposal Unit Price (KRW)** | Remarks | Trading plan report date | ||
| Before Change | Change | After Change | ||||||
| On-Market Purchase (+) | 2026-11-04 | Common Stock | 18,449 | 29,000 | 47,449 | 1,131 | - | - |
| On-Market Purchase (+) | 2026-11-05 | Common Stock | 47,449 | 39,000 | 86,449 | 1,150 | - | - |
| 장외매수(+) | 2026-11-05 | Common Stock | 86,449 | 55,000 | 141,449 | 1,179 | 동현철 | - |
| On-Market Purchase (+) | 2026-11-06 | Common Stock | 141,449 | 3,000 | 144,449 | 1,168 | - | - |
| On-Market Purchase (+) | 2026-11-09 | Common Stock | 144,449 | 11,500 | 155,949 | 1,161 | - | - |
| Total | 18,449 | 137,500 | 155,949 | - | - | |||
* For trades on the securities market, the settlement date
** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities